MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2016 International Congress

    Bacterial biofilm formation on neurostimulation systems

    A. Wloch, B. Hong, M. Abdallat, A. Winkel, A. Saryyeva, G. Lütjens, M. Stiesch, J.K. Krauss (Hannover, Germany)

    Objective: The aim of this study is to identify specifically the DNA of bacterial biofilm on neurostimulation systems using polymerase chain reaction (PCR). Background: Bacterial…
  • 2016 International Congress

    Phenomenology of idiopathic adult-onset truncal dystonia

    D.J. Ehrlich, S.J. Frucht (New York, NY, USA)

    Objective: Characterize the phenomenology and natural history of adult onset idiopathic truncal dystonia. Background: Focal dystonias are the most common type of adult-onset dystonia, however,…
  • 2016 International Congress

    Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

    W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To compare standard botulinum toxin (BoNT) versus physical therapy (PT) combined with BoNT in primary cervical dystonia (PCD). Background: PCD is frequently a source…
  • 2016 International Congress

    Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray

    M. Aguilar, S. Romero, L. Molina Porcel, P. Pastor (Terrassa, Spain)

    Objective: We performed an open study of delta-9-tetrahydrocannabinol and cannabidiol (THC:CBD) oromucosal spray (Nabiximols, Sativex®) in 6 patients with suboptimal responsive adult-onset dystonia. Background: Cannabinoids…
  • 2016 International Congress

    Effectiveness of bilateral pallidal deep brain stimulation in a patient with dystonia associated to neurodegenerative ataxia: Follow-up to 18 months

    P.A. Millan, J.M. Cardenas (Cali, Colombia)

    Objective: CASE REPORT Background: The dystonia like others movement disorder may be included in neurodegenerative ataxia syndrome, in addition to cerebellar dysfunction. The pallidal stimulation…
  • 2016 International Congress

    Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions

    M.S. Jog, R.M. Jog, A. Tewari, D. Hobson, D. Stewart, D. King (London, ON, Canada)

    Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…
  • 2016 International Congress

    Improvement of levodopa induced foot dystonia with 60 Hz frequency subthalamic- deep brain stimulation

    J.P. Battista, R.A. Ramdhani (New York, NY, USA)

    Objective: To present a case of levodopa induced foot dystonia that improved with 60Hz frequency subthalamic- deep brain stimulation. Background: Deep Brain Stimulation is an…
  • 2016 International Congress

    Toward clinical use of electrode localizations in deep brain stimulation therapy

    S. Ewert, A. Horn, P. Plettig, M. Ruch, A. Kühn (Berlin, Germany)

    Objective: To develop an open source software capable of performing electrode localizations certified for clinical use in deep brain stimulation therapy. Background: Deep brain stimulation…
  • 2016 International Congress

    Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients

    L. Lowry, B. Hammersley, M. Bonello, P. Byrne, N.A. Fletcher, J.O. Farah, P.R. Eldridge, S.H. Alusi (Liverpool, United Kingdom)

    Objective: To study the efficacy of GPi DBS surgery in improving dystonia related severity, disability and pain as well as quality of life in medically…
  • 2016 International Congress

    Endoscopic-guided injection of botulinum toxin into the longus capitis muscle and into the obliquus superior part of the longus colli muscle in dystonic antecaput

    G. Reichel, A. Stenner, H. von Sanden, L. Herrmann, C. Feja, S. Löffler (Zwickau, Germany)

    Objective: Cervical dystonia is the most commonly described dystonia. Since examinations of the muscle using imaging techniques were started [1], the classification of the phenomenological…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley